Selected research
Market Structure
Global D(-)-Alpha-Phenylglycine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global D(-)-Alpha-Phenylglycine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for D(-)-Alpha-Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for D(-)-Alpha-Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for D(-)-Alpha-Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for D(-)-Alpha-Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of D(-)-Alpha-Phenylglycine include Zhejiang Yuntao Biotechnology, JIN Yimeng Group and Hebei Zeshuo Pharmaceutical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global D(-)-Alpha-Phenylglycine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of D(-)-Alpha-Phenylglycine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents D(-)-Alpha-Phenylglycine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the D(-)-Alpha-Phenylglycine market size, projected growth trends, production technologies, key applications, and end-use industries.
D(-)-Alpha-Phenylglycine Segment by Company
Zhejiang Yuntao Biotechnology
JIN Yimeng Group
Hebei Zeshuo Pharmaceutical Technology
D(-)-Alpha-Phenylglycine Segment by Type
Purity ≥98.5%
Purity <98.5%
D(-)-Alpha-Phenylglycine Segment by Application
Penicillin Intermediates
Cephalexin Intermediates
D(-)-Alpha-Phenylglycine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global D(-)-Alpha-Phenylglycine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of D(-)-Alpha-Phenylglycine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of D(-)-Alpha-Phenylglycine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the D(-)-Alpha-Phenylglycine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of D(-)-Alpha-Phenylglycine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of D(-)-Alpha-Phenylglycine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of D(-)-Alpha-Phenylglycine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥98.5%
- Purity <98.5%
Applications
- Penicillin Intermediates
- Cephalexin Intermediates
Companies covered
- Zhejiang Yuntao Biotechnology
- JIN Yimeng Group
- Hebei Zeshuo Pharmaceutical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global D(-)-Alpha-Phenylglycine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global D(-)-Alpha-Phenylglycine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global D(-)-Alpha-Phenylglycine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global D(-)-Alpha-Phenylglycine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global D(-)-Alpha-Phenylglycine Market Dynamics
- 2.1 D(-)-Alpha-Phenylglycine Industry Trends
- 2.2 D(-)-Alpha-Phenylglycine Industry Drivers
- 2.3 D(-)-Alpha-Phenylglycine Industry Opportunities and Challenges
- 2.4 D(-)-Alpha-Phenylglycine Industry Restraints
3 D(-)-Alpha-Phenylglycine Market by Manufacturers
- 3.1 Global D(-)-Alpha-Phenylglycine Revenue by Manufacturers (2021-2026)
- 3.2 Global D(-)-Alpha-Phenylglycine Sales by Manufacturers (2021-2026)
- 3.3 Global D(-)-Alpha-Phenylglycine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global D(-)-Alpha-Phenylglycine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global D(-)-Alpha-Phenylglycine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global D(-)-Alpha-Phenylglycine Manufacturers, Product Type & Application
- 3.7 Global D(-)-Alpha-Phenylglycine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global D(-)-Alpha-Phenylglycine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 D(-)-Alpha-Phenylglycine Players Market Share by Revenue in 2025
- 3.8.3 2025 D(-)-Alpha-Phenylglycine Tier 1, Tier 2, and Tier 3
4 D(-)-Alpha-Phenylglycine Market by Type
- 4.1 D(-)-Alpha-Phenylglycine Type Introduction
- 4.1.1 Purity ≥98.5%
- 4.1.2 Purity <98.5%
- 4.2 Global D(-)-Alpha-Phenylglycine Sales by Type
- 4.2.1 Global D(-)-Alpha-Phenylglycine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global D(-)-Alpha-Phenylglycine Sales by Type (2021-2032)
- 4.2.3 Global D(-)-Alpha-Phenylglycine Sales Market Share by Type (2021-2032)
- 4.3 Global D(-)-Alpha-Phenylglycine Revenue by Type
- 4.3.1 Global D(-)-Alpha-Phenylglycine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global D(-)-Alpha-Phenylglycine Revenue by Type (2021-2032)
- 4.3.3 Global D(-)-Alpha-Phenylglycine Revenue Market Share by Type (2021-2032)
5 D(-)-Alpha-Phenylglycine Market by Application
- 5.1 D(-)-Alpha-Phenylglycine Application Introduction
- 5.1.1 Penicillin Intermediates
- 5.1.2 Cephalexin Intermediates
- 5.2 Global D(-)-Alpha-Phenylglycine Sales by Application
- 5.2.1 Global D(-)-Alpha-Phenylglycine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global D(-)-Alpha-Phenylglycine Sales by Application (2021-2032)
- 5.2.3 Global D(-)-Alpha-Phenylglycine Sales Market Share by Application (2021-2032)
- 5.3 Global D(-)-Alpha-Phenylglycine Revenue by Application
- 5.3.1 Global D(-)-Alpha-Phenylglycine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global D(-)-Alpha-Phenylglycine Revenue by Application (2021-2032)
- 5.3.3 Global D(-)-Alpha-Phenylglycine Revenue Market Share by Application (2021-2032)
6 Global D(-)-Alpha-Phenylglycine Sales by Region
- 6.1 Global D(-)-Alpha-Phenylglycine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global D(-)-Alpha-Phenylglycine Sales by Region (2021-2032)
- 6.2.1 Global D(-)-Alpha-Phenylglycine Sales by Region (2021-2026)
- 6.2.2 Global D(-)-Alpha-Phenylglycine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America D(-)-Alpha-Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America D(-)-Alpha-Phenylglycine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe D(-)-Alpha-Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe D(-)-Alpha-Phenylglycine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific D(-)-Alpha-Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific D(-)-Alpha-Phenylglycine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa D(-)-Alpha-Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa D(-)-Alpha-Phenylglycine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global D(-)-Alpha-Phenylglycine Revenue by Region
- 7.1 Global D(-)-Alpha-Phenylglycine Revenue by Region
- 7.1.1 Global D(-)-Alpha-Phenylglycine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global D(-)-Alpha-Phenylglycine Revenue by Region (2021-2026)
- 7.1.3 Global D(-)-Alpha-Phenylglycine Revenue by Region (2027-2032)
- 7.1.4 Global D(-)-Alpha-Phenylglycine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America D(-)-Alpha-Phenylglycine Revenue (2021-2032)
- 7.2.2 North America D(-)-Alpha-Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe D(-)-Alpha-Phenylglycine Revenue (2021-2032)
- 7.3.2 Europe D(-)-Alpha-Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific D(-)-Alpha-Phenylglycine Revenue (2021-2032)
- 7.4.2 Asia-Pacific D(-)-Alpha-Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa D(-)-Alpha-Phenylglycine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa D(-)-Alpha-Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zhejiang Yuntao Biotechnology
- 8.1.1 Zhejiang Yuntao Biotechnology Company Information
- 8.1.2 Zhejiang Yuntao Biotechnology Business Overview
- 8.1.3 Zhejiang Yuntao Biotechnology D(-)-Alpha-Phenylglycine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zhejiang Yuntao Biotechnology D(-)-Alpha-Phenylglycine Product Portfolio
- 8.1.5 Zhejiang Yuntao Biotechnology Recent Developments
- 8.2 JIN Yimeng Group
- 8.2.1 JIN Yimeng Group Company Information
- 8.2.2 JIN Yimeng Group Business Overview
- 8.2.3 JIN Yimeng Group D(-)-Alpha-Phenylglycine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 JIN Yimeng Group D(-)-Alpha-Phenylglycine Product Portfolio
- 8.2.5 JIN Yimeng Group Recent Developments
- 8.3 Hebei Zeshuo Pharmaceutical Technology
- 8.3.1 Hebei Zeshuo Pharmaceutical Technology Company Information
- 8.3.2 Hebei Zeshuo Pharmaceutical Technology Business Overview
- 8.3.3 Hebei Zeshuo Pharmaceutical Technology D(-)-Alpha-Phenylglycine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hebei Zeshuo Pharmaceutical Technology D(-)-Alpha-Phenylglycine Product Portfolio
- 8.3.5 Hebei Zeshuo Pharmaceutical Technology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 D(-)-Alpha-Phenylglycine Value Chain Analysis
- 9.1.1 D(-)-Alpha-Phenylglycine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 D(-)-Alpha-Phenylglycine Production Mode & Process
- 9.2 D(-)-Alpha-Phenylglycine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 D(-)-Alpha-Phenylglycine Distributors
- 9.2.3 D(-)-Alpha-Phenylglycine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst